Asthma patients to be shown leaflets detailing climate impact of inhalers as NHS estimates they account for 3pc of their ...
PT027 (albuterol/budesonide) is a potential first-in-class inhaled, fixed-dose combination of the short-acting beta2-agonist albuterol and budesonide, an inhaled corticosteroid. It is currently ...
Doctors have been told to stop ­prescribing blue asthma ­inhalers used by millions of patients under NHS ­guidance that says ...
The National Institute for Health and Care Excellence (NICE) advises the blue inhaler, over 17 million of which were ...
About The Study: In this network meta-analysis of patients with asthma, inhaled corticosteroids combined with formoterol and inhaled corticosteroids combined with short-acting β agonists were ...
Australia may soon follow changes made to asthma treatment and management in the UK, where doctors have been ­advised to stop ...
It recommends healthcare practitioners should offer a low-dose combination of inhaled corticosteroids (ICS) and formoterol to be taken as needed for everyone aged 12 and over with newly diagnosed ...
In a “true pivot” in asthma care across the UK, new guidelines urge medics to offer inhalers that both relieve and prevent ...